Table 2.
Comparison of risk factors for the development of ESBL-E infections in the study groups
| P value | Women with non-ESBL-E-positive urine cultures (N = 174) (%) | Women with ESBL-E-positive urine cultures (N = 87) (%) | |
|---|---|---|---|
| <0.001 | 42 (26.3) | 40 (50.6) | UTI/ABU in the previous year |
| <0.001 | 1 (0.6) | 11 (12.6) | Prior ESBL-E-positive cultures |
| 0.39 | 49 (28.1) | 29 (33.3) | Hospitalisation in the previous 6 months |
| 0.50 | 36 (20.6) | 15 (17.2) | Hospital-acquired UTI/ABUa |
| 0.002 | 94 (54) | 62 (71.3) | Antibiotic use in the previous 6 months |
| 0.58 | 119 (68.2) | 59 (67.8) | No underlying medical conditionsb |
| 0.47 | 9 (5.2) | 5 (5.7) | Urinary tract abnormalities |
| 0.56 | 20 (11.5) | 12 (13.8) | Diabetes mellitus |
a
Defined as urine cultures obtained 72 h or more following hospitalisation, or from patients who were hospitalised within the previous 2 weeks.
b
Defined as any chronic medical condition other than anaemia, including: hepatitis, Antiphospholipid syndrome, epilepsy, psychiatric problems, hypertension, thyroid disease, asthma and chronic steroid treatment.